trial

Study of Injectable Naltrexone and Oral Bupropion Among Cigarette Smokers With Schizophrenia

NCTId NCT06374290
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
Phase 1 · Terminated
Enrollment 2 (actual)
Sponsored by The University of Texas Health Science Center, Houston
Primary completion 2024-12-04
Synthesized from structured facts only — each point cited above.

Design & status

Phase
Phase 1
Status
Terminated
Enrollment
2 (actual)
Study type
Interventional
Allocation
Na
Model
Single Group
Masking
None
Start
2024-07-16
Primary completion
2024-12-04
Eligibility
ALL · 18 Years

Interventions & indications

Drugs
Naltrexone (Vivitrol)Bupropion

Sponsors

The University of Texas Health Science Center, HoustonLead Sponsor

Investigators

1
Jin Ho Yoon, PhDPrincipal Investigator

Sites

1 total
Houston, United States

Facts & assertions

4 sourced
Enrollment
2
Phase
PHASE1
Primary Completion Date
2024-12-04
Status
TERMINATED
relationships
The graph out of here
drug
Naltrexone (Vivitrol)
drug
Bupropion
drug
lead_sponsor
The University of Texas Health Science Center, Houston
company
indication
Smoking Cessation
indication
Smoking Cessation
indication
investigator
Jin Ho Yoon, PhD
person